We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-15.19%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.4B
AUM Growth
-$2.53B
Cap. Flow
-$239M
Cap. Flow %
-2.3%
Top 10 Hldgs %
18.85%
Holding
2,568
New
165
Increased
997
Reduced
1,065
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 7.95%
2 Healthcare 4.79%
3 Financials 4.53%
4 Consumer Discretionary 3.82%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDLI
2201
DELISTED
PDL BioPharma, Inc.
PDLI
$37K ﹤0.01%
+13,082
New +$42.2K
CPIX icon
2202
Cumberland Pharmaceuticals
CPIX
$119M
$36K ﹤0.01%
10,000
AGEN
2203
Agenus
AGEN
$311M
$34K ﹤0.01%
704
-26
-4% -$1.63K
GPRO icon
2204
GoPro
GPRO
$106M
$34K ﹤0.01%
12,877
-33,062
-72% -$123K
CX icon
2205
Cemex
CX
$16.2B
$33K ﹤0.01%
15,767
-329
-2% -$1.11K
MUX icon
2206
McEwen Inc
MUX
$1.18B
$32K ﹤0.01%
4,868
+349
+8% +$3.6K
SAN icon
2207
Banco Santander
SAN
$211B
$32K ﹤0.01%
14,034
-10,294
-42% -$35.3K
AQB icon
2208
AquaBounty Technologies
AQB
$7.1M
$31K ﹤0.01%
+937
New +$37.9K
SOHO
2209
DELISTED
Sotherly Hotels
SOHO
$30K ﹤0.01%
18,833
+7,425
+65% +$36.9K
SIEN
2210
DELISTED
Sientra, Inc.
SIEN
$30K ﹤0.01%
+1,514
New +$79K
AEG icon
2211
Aegon
AEG
$13.9B
$29K ﹤0.01%
12,789
-12,214
-49% -$40.7K
TXMD icon
2212
TherapeuticsMD
TXMD
$24.1M
$29K ﹤0.01%
545
-56
-9% -$5.55K
MNK
2213
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$29K ﹤0.01%
+14,874
New +$56.4K
HOME
2214
DELISTED
At Home Group Inc.
HOME
$28K ﹤0.01%
+13,705
New +$67.3K
ABEV icon
2215
Ambev
ABEV
$43.5B
$27K ﹤0.01%
+11,876
New +$43K
CLNE icon
2216
Clean Energy Fuels
CLNE
$384M
$27K ﹤0.01%
15,009
+2,110
+16% +$4.76K
PNNT
2217
Pennant Park Investment Corp
PNNT
$249M
$27K ﹤0.01%
10,276
-298
-3% -$1.65K
PXJ icon
2218
Invesco Oil & Gas Services ETF
PXJ
$64.9M
$27K ﹤0.01%
2,902
+372
+15% +$7.18K
NE
2219
DELISTED
Noble Corporation
NE
$27K ﹤0.01%
103,682
-240,854
-70% -$179K
ATER icon
2220
Aterian
ATER
$5.09M
$26K ﹤0.01%
+1,293
New +$63.5K
MFG icon
2221
Mizuho Financial
MFG
$132B
$26K ﹤0.01%
+11,453
New +$31.3K
JMF
2222
DELISTED
NUVEEN ENERGY MLP TOTAL RETURN FUND
JMF
$26K ﹤0.01%
17,789
+2,996
+20% +$17.3K
HL icon
2223
Hecla Mining
HL
$12.2B
$25K ﹤0.01%
13,812
+2,001
+17% +$5.54K
TUES
2224
DELISTED
Tuesday Morning Corp
TUES
$25K ﹤0.01%
43,400
+2,000
+5% +$2.86K
FMO
2225
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$24K ﹤0.01%
3,732
-355
-9% -$10.2K

Similar funds

Cambridge Investment Research Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Cambridge Investment Research Advisors held 2,568 positions worth $10.4B, down 20% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors's Q1 2020 filing shows 165 new, 997 increased, 1,065 reduced and 296 closed positions. Its largest new stake was iShares GNMA Bond ETF: 171,895 shares worth $8.87M. The largest sale was Vanguard S&P 500 ETF, an estimated $94M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Financials.

  • Cambridge Investment Research Advisors's largest Q1 2020 buy was iShares GNMA Bond ETF: 171,895 shares worth $8.87M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q1 2020, an estimated $80.7M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $94M.
  • Cambridge Investment Research Advisors fully exited Schwab Fundamental International Small Company Index ETF in Q1 2020, selling an estimated $10.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.4B portfolio in Q1 2020.
  • Cambridge Investment Research Advisors opened 165 new positions and closed 296 in Q1 2020.
  • Cambridge Investment Research Advisors's portfolio value fell 20% quarter-over-quarter to $10.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.